Guyasuta Investment Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Guyasuta Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-10,042	Closed	-$462K	–	216
2016 Q3	$462K	Sell	10,042 -3,900	-28%	-$203K	0.06%	140
2016 Q2	$700K	Buy	13,942 +2,500	+22%	+$133K	0.09%	110
2016 Q1	$612K	Buy	11,442 +5,975	+109%	+$351K	0.09%	118
2015 Q4	$358K	Buy	+5,467	New	+$338K	0.05%	152

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Guyasuta Investment Advisors's TEVA Position: Q4 2016 in Review

Guyasuta Investment Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 10,042 shares — an estimated $462K sold.

Guyasuta Investment Advisors first reported a position in TEVA in Q4 2015 and held it in 4 quarters. The position peaked at $700K in Q2 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

Guyasuta Investment Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
Guyasuta Investment Advisors sold 10,042 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $462K.
Guyasuta Investment Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q4 2015 and held it in 4 quarters.
Guyasuta Investment Advisors's Teva Pharmaceutical Industries Limited position peaked at $700K in Q2 2016.
739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on Guyasuta Investment Advisors's 13F filing for Q4 2016, filed 7 Feb 2017.